Organicell Regenerative Medicine (BPSR) News Today $2.09 +0.09 (+4.50%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Organicell Regenerative Medicine Inc (OTC:OCEL) Stock Quotes, Forecast and News SummaryOctober 17, 2024 | benzinga.comZeo ScientifiX, Inc. (ZEOX)July 20, 2024 | finance.yahoo.comZEO ScientifiX, Inc.: Organicell Regenerative Medicine Rebranding to ZEO ScientifiXMarch 4, 2024 | finanznachrichten.deOrganicell Regenerative Medicine Inc (OCELD)December 17, 2023 | uk.investing.comOCELD Organicell Regenerative Medicine, Inc.December 2, 2023 | seekingalpha.comOrganicell Regenerative Stock (OTC:OCEL) Dividends: History, Yield and DatesNovember 30, 2023 | benzinga.comOrganicell Announces 1-for-200 Reverse Stock SplitNovember 27, 2023 | finance.yahoo.comOrganicell Regenerative Medicine, Inc.: Organicell Reports Interim Results of Phase 1/2A Research ProgramJuly 28, 2023 | finanznachrichten.deOrganicell Reports Interim Results of Phase 1/2A Research ProgramJuly 26, 2023 | finance.yahoo.comOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOJune 29, 2023 | finanznachrichten.deOrganicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOJune 29, 2023 | finance.yahoo.comOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Harry Leider, MD, MBA as its New CEOJune 23, 2023 | finanznachrichten.de8-K: Organicell Regenerative Medicine, Inc.June 22, 2023 | marketwatch.comOrganicell Welcomes Harry Leider, MD, MBA as its New CEOJune 21, 2023 | finance.yahoo.comGlobal Regenerative Medicine Market [2023-2030] | Latest Trends and Insights | Market to Reach Worth USD 116410 MillionMay 5, 2023 | marketwatch.comCan regenerative wool make fashion more sustainable?May 4, 2023 | bbc.comOrganicell Regenerative Medicine Inc (OCEL)April 6, 2023 | investing.comOCEL Organicell Regenerative Medicine, Inc.April 5, 2023 | seekingalpha.comRegenerative Medicine Market Trends for Future Success 2023-2028March 29, 2023 | marketwatch.comRegenerative Medicine Market 2023: Growing Opportunities by 2028March 29, 2023 | marketwatch.comRegenerative Medicine Market Report 2023-2033March 18, 2023 | finance.yahoo.comMount Vernon, IN Regenerative Medicine Procedures Launched By NuYou TherapiesFebruary 22, 2023 | finance.yahoo.comRegenerative Medicine Market Regional Outlook & Size Projections with SWOT Analysis to Witness Rapid Growth 2026January 17, 2023 | marketwatch.comRegenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical AilmentsJanuary 14, 2023 | finance.yahoo.comRegenerative Medicine for Cartilage Market Industry Expansion Strategies till 2028 with SWOT & RISK AnalysisJanuary 14, 2023 | marketwatch.comOrganicell Regenerative Medicine Inc.January 14, 2023 | wsj.comThe Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic ConditionsJanuary 11, 2023 | finance.yahoo.comRegenerative Medicine Market worth $40.6 billion by 2027 - Exclusive Report by MarketsandMarkets™January 7, 2023 | finance.yahoo.comOTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷November 22, 2022 | finance.yahoo.comOrganicell Starts Enrolling Long COVID TrialNovember 17, 2022 | ca.finance.yahoo.comCan This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?November 17, 2022 | yahoo.comEQS-News: Can This Companys Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?November 14, 2022 | markets.businessinsider.comCan This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?November 14, 2022 | benzinga.comIs It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?November 10, 2022 | benzinga.comOrganicell Regenerative Medicine, Inc. (OCEL)October 19, 2022 | sg.finance.yahoo.comOrganicell Regenerative Medicine Broadens Access to Valued Business Expertise and Relationship With New Additions to Board of DirectorsOctober 13, 2022 | benzinga.comOrganicell Regenerative Medicine secures additional $11M financing for clinical trial enrollmentSeptember 9, 2022 | seekingalpha.comOrganicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial EnrollmentSeptember 9, 2022 | apnews.comOrganicell Regenerative Medicine, Inc. Engages Law Firm McDermott Will & EmeryAugust 30, 2022 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial ActivitiesDecember 29, 2021 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. Uplist Of Common Stock To OTCQB ApprovedNovember 9, 2021 | finance.yahoo.comFINRA Approves Marketplace Name Change to Organicell Regenerative Medicine, Inc. and Trading Symbol Change To "OCEL"November 5, 2021 | finance.yahoo.comOrganicell Regenerative Medicine, Inc. (BPSR)August 13, 2021 | finance.yahoo.com Get Organicell Regenerative Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for BPSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW BPSR Media Mentions By Week BPSR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPSR News Sentiment▼0.000.60▲Average Medical News Sentiment BPSR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPSR Articles This Week▼00▲BPSR Articles Average Week Get Organicell Regenerative Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for BPSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today APLMW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today AXIM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BPSR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organicell Regenerative Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organicell Regenerative Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
